Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.3M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 48 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 1,459 | — | — | — | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 200 | $94.02 | $18.8K | -1.3% | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,208 | $93.26 | $205.9K | -12.5% | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,051 | $92.41 | $374.4K | -18.6% | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 3,000 | $91.11 | $273.3K | -12.1% | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 1,459 | $34.39 | $50.2K | +6.3% | Open the original filing on SEC.gov |
| Sep 11 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 8,000 | $12.50 | $100K | +52.3% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 1,458 | — | — | — | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 8,542 | — | — | — | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,358 | $108.46 | $255.8K | -13.3% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,142 | $107.71 | $230.7K | -10.8% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,268 | $106.63 | $135.2K | -6.0% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,132 | $105.57 | $225.1K | -9.2% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 2,100 | $104.67 | $219.8K | -8.3% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 1,458 | $34.39 | $50.1K | +6.1% | Open the original filing on SEC.gov |
| Aug 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 8,542 | $12.50 | $106.8K | +55.8% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 1,458 | — | — | — | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 8,541 | — | — | — | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 300 | $85.63 | $25.7K | -1.9% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 5,656 | $84.90 | $480.2K | -26.6% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 3,743 | $84.26 | $315.4K | -15.0% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 300 | $83.07 | $24.9K | -1.2% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 1,458 | $34.39 | $50.1K | +6.1% | Open the original filing on SEC.gov |
| Jul 13 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 8,541 | $12.50 | $106.8K | +55.8% | Open the original filing on SEC.gov |
| Jun 22 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 699 | $82.15 | $57.4K | -4.4% | Open the original filing on SEC.gov |
| Jun 22 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 888 | $80.01 | $71K | -5.3% | Open the original filing on SEC.gov |
| Jun 15 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 395 | $69.69 | $27.5K | -2.3% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 1,459 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 3,260 | $70.34 | $229.3K | -15.9% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,340 | $69.85 | $303.2K | -17.4% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 1,859 | $68.34 | $127K | -7.0% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 1,459 | $34.39 | $50.2K | +5.8% | Open the original filing on SEC.gov |
| Jun 12 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 8,000 | $12.50 | $100K | +46.3% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 5,833 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | MEXER◷◆ | 2,000 | — | — | — | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 700 | $61.16 | $42.8K | -4.1% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 800 | $60.34 | $48.3K | -4.5% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,600 | $59.19 | $272.3K | -20.4% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | SSELL◷ | 4,190 | $58.34 | $244.5K | -15.7% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 5,833 | $34.39 | $200.6K | +28.0% | Open the original filing on SEC.gov |
| May 18 | ORKA | Oruka Therapeutics, Inc. | MEXER◷ | 2,000 | $12.50 | $25K | +10.6% | Open the original filing on SEC.gov |
| Mar 16 | ORKA | Oruka Therapeutics, Inc. | SSELL | 395 | $41.30 | $16.3K | -2.1% | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 70,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 23 | ORKA | Oruka Therapeutics, Inc. | AGRANT | 17,500 | — | — | +995.4% | Open the original filing on SEC.gov |